Concepedia

Publication | Open Access

Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib

DOIFull Paper Access

33

Citations

18

References

2020

Year

Naoki Fukuda, Xiaofei Wang, Akihiro Ohmoto, Tetsuya Urasaki, Yasuyoshi Sato, Kenji Nakano, Masatoshi Nishizawa, Mayu Yunokawa, Makiko Ono, Junichi Tomomatsu,
In Vivo

Abstract

NLR values vary before and during lenvatinib treatment, suggesting that this ratio can reflect disease activity of RR-DTC. NLR can supportively be used as a tumor marker of RR-DTC and an indicator for starting lenvatinib treatment.

References

YearCitations

Page 1